BHVN logo

Biohaven Ltd. (BHVN)

Profile

Full Name

Biohaven Ltd.

Ticker

NYSE: BHVN

Exchange

NYSE

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

September 23, 2022

Indexes

Not included

Website

https://www.biohaven.com

Employees

256

Key Details

Price

$15.52(+5.58%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$9.28(-61.95% YoY)

PE ratio

-

Next earnings date

Nov 10, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $15.52
    BHVN price is $15.52

    30-Day Relative Volume

    1.70
    BHVN 30-day relative volume is 1.70

    Price Performance

    Price Today change

    +5.58%
    BHVN price is up +5.58% today

    Price YTD change

    -58.45%
    BHVN price is down -58.45% since January 1st

    Price 1-year change

    -60.61%
    BHVN price is down -60.61% year-on-year

    Price 3-year change

    -89.73%
    BHVN price is down -89.73% over the past 3 years

    Price Range

    Price All-time high

    $151.25
    BHVN price is currently -89.74% below its historical high of $151.25

    Price 3-year low

    $5.54
    BHVN price is currently +180.14% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.64B
    BHVN market capitalization is $1.64 billion

    Market cap 3-year change

    -83.12%
    BHVN market capitalization is down -83.12% over the past 3 years

    Market cap All-time high

    $9.95B
    BHVN market capitalization is currently -83.50% below its historical high of $9.95 billion

    Market cap sector rank

    77.94%
    BHVN market capitalization is higher than 77.94% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +11.9%
    BHVN shares outstanding is up +11.9% year-on-year

    Shares Outstanding 3-Year Change

    +64.33%
    BHVN shares outstanding is up +64.33% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.60
    BHVN beta is 1.60

    200-day SMA

    $24.60
    BHVN price is currently -36.90% below its 200-day simple moving average

    50-day SMA

    $14.61
    BHVN price is currently +6.23% above its 50-day simple moving average

    RSI

    55.85
    BHVN 14-day relative strength index is 55.85

    Volume

    1.70
    BHVN 30-day relative volume is 1.70

    ATR

    $0.92
    BHVN average true range is $0.92

    10-day Historical Volatility

    75.49%
    BHVN 10-day historical volatility is 75.49%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    BHVN annual revenue is $0.00

    Revenue Analysts estimate

    $2.93M
    BHVN annual revenue is currently -100.00% lower than the consensus analysts' forecast

    Revenue 1-year change

    0%
    BHVN annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.79%
    BHVN annual revenue is higher than 28.79% of companies in Healthcare sector

    EPS

    EPS

    -$9.28
    BHVN annual earnings per share is -$9.28

    EPS Analysts estimate

    -$6.28
    BHVN annual earnings per share is currently +47.88% higher than the consensus analysts' forecast

    EPS 1-year change

    -61.95%
    BHVN annual earnings per share is down -61.95% year-on-year

    EPS Sector rank

    13.94%
    BHVN annual earnings per share is higher than 13.94% of companies in Healthcare sector

    Profit

    Gross profit

    -$3.92M
    BHVN annual gross profit is -$3.92 million

    Gross margin

    -
    BHVN annual gross profit margin value is unknown

    Operating profit

    -$885.11M
    BHVN annual operating income is -$885.11 million

    Operating margin

    -
    BHVN annual operating profit margin value is unknown

    Net income

    -$846.42M
    BHVN annual net profit is -$846.42 million

    Net margin

    -
    BHVN annual net profit margin value is unknown

    Expenses

    Total expenses

    $885.11M
    BHVN annual total expenses is $885.11 million

    Operating expenses

    $885.11M
    BHVN annual total operating expenses is $885.11 million

    Cost of goods sold

    $3.92M
    BHVN annual cost of goods sold is $3.92 million

    Selling, general & administrative expenses

    $89.24M
    BHVN annual SGA is $89.24 million

    Depreciation and amortization

    $7.86M
    BHVN annual depreciation & amortization is $7.86 million

    Interest expense

    $0.00
    BHVN annual interest expense is $0.00

    Income tax

    $735.00K
    BHVN annual income tax is $735.00 thousand

    EBIT & EBITDA

    EBIT

    -$885.11M
    BHVN annual earnings before interest & taxes is -$885.11 million

    EBITDA

    -$877.26M
    BHVN annual EBITDA is -$877.26 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $615.11M
    BHVN annual total assets is $615.11 million

    Non current assets

    $76.64M
    BHVN annual long term assets is $76.64 million

    Current assets

    $538.47M
    BHVN annual total current assets is $538.47 million

    Cash and cash equivalents

    $99.13M
    BHVN annual cash & cash equivalents is $99.13 million

    Accounts receivable

    -
    BHVN annual accounts receivable value is unknown

    Inventory

    $0.00
    BHVN annual inventory is $0.00

    Liabilities

    Total liabilities

    $191.67M
    BHVN annual total liabilities is $191.67 million

    Long term liabilities

    $37.45M
    BHVN annual total long term liabilities is $37.45 million

    Current liabilities

    $154.23M
    BHVN annual total current liabilities is $154.23 million

    Accounts payable

    $18.03M
    BHVN annual accounts payable is $18.03 million

    Debt

    Total debt

    $36.58M
    BHVN annual total debt is $36.58 million

    Total debt 1-year change

    +18.48%
    BHVN annual total debt is up +18.48% year-on-year

    Long term debt

    $32.78M
    BHVN annual long term debt is $32.78 million

    Short term debt

    $3.80M
    BHVN annual short term debt is $3.80 million

    Equity & Capital

    Shareholders equity

    $423.44M
    BHVN annual stockholders equity is $423.44 million

    Book value

    $423.44M
    BHVN annual book value is $423.44 million

    Retained earnings

    -$1.35B
    BHVN annual retained earnings is -$1.35 billion

    Working capital

    $384.25M
    BHVN annual working capital is $384.25 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$582.45M
    BHVN annual cash flow from operations is -$582.45 million

    Cash from operations 1-year change

    -75.58%
    BHVN annual cash flow from operations is down -75.58% year-on-year

    Cash from investing

    -$244.97M
    BHVN annual cash flow from investing activities is -$244.97 million

    Cash from investing 1-year change

    -288.69%
    BHVN annual cash flow from investing activities is down -288.69% year-on-year

    Cash from financing

    $677.77M
    BHVN annual cash flow from financing activities is $677.77 million

    Cash from financing 1-year change

    +219.84%
    BHVN annual cash flow from financing activities is up +219.84% year-on-year

    CAPEX

    CAPEX

    $4.05M
    BHVN annual capital expenditures is $4.05 million

    CAPEX 1-year change

    +32.84%
    BHVN annual capital expenditures is up +32.84% year-on-year

    Free Cash Flow

    Free cash flow

    -$586.50M
    BHVN annual free cash flow is -$586.50 million

    Free cash flow 1-year change

    -75.19%
    BHVN annual free cash flow is down -75.19% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    BHVN annual gross profit margin value is unknown

    Operating margin

    -
    BHVN annual operating profit margin value is unknown

    Net margin

    -
    BHVN annual net profit margin value is unknown

    ROA & ROE

    ROA

    -150.03%
    BHVN annual return on assets is -150.03%

    ROE

    -198.83%
    BHVN annual return on equity is -198.83%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    BHVN price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    BHVN price to earnings ratio is unknown

    PB Ratio

    PB ratio

    12.20
    BHVN price to book ratio is 12.20

    PB ratio Sector rank

    90.33%
    BHVN price to book ratio is higher than 90.33% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    BHVN price to sales ratio value is unknown

    PS ratio Sector rank

    -
    BHVN price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $1.53B
    BHVN enterprise value is $1.53 billion

    Enterprise value Sector rank

    77.33%
    BHVN enterprise value is higher than 77.33% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.92
    BHVN EV/EBITDA is -1.92

    EV/EBITDA Sector rank

    38.39%
    BHVN EV/EBITDA is higher than 38.39% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.49
    BHVN annual current ratio is 3.49

    Quick ratio

    3.49
    BHVN annual quick ratio is 3.49

    Leverage

    Debt to equity

    0.09
    BHVN annual debt to equity ratio is 0.09

    Interest coverage ratio

    -
    BHVN annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    BHVN piotroski f-score value is unknown

    Altman Z-Score

    -1.92
    BHVN altman z-score is -1.92

    Analyst ratings

    Recent major analysts updates

    Sep 3, 25 Raymond James
    Strong Buy
    Aug 19, 25 BTIG
    Buy
    Aug 12, 25 Morgan Stanley
    Overweight
    Aug 12, 25 Leerink Partners
    Outperform
    Aug 12, 25 HC Wainwright & Co.
    Buy
    Aug 12, 25 Baird
    Outperform
    Aug 12, 25 B of A Securities
    Buy
    Jun 18, 25 JP Morgan
    Overweight
    May 19, 25 RBC Capital
    Sector Perform
    May 13, 25 RBC Capital
    Outperform

    Institutional Ownership

    Screeners with BHVN included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    Stocks below analysts price target
    Healthcare sector
    All stocks
    Biotech Companies
    Ex Dividend dates calendar
    • What is the ticker symbol for Biohaven Ltd.?
    • Does Biohaven Ltd. pay dividends?
    • What sector is Biohaven Ltd. in?
    • What industry is Biohaven Ltd. in?
    • What country is Biohaven Ltd. based in?
    • When did Biohaven Ltd. go public?
    • Is Biohaven Ltd. in the S&P 500?
    • Is Biohaven Ltd. in the NASDAQ 100?
    • Is Biohaven Ltd. in the Dow Jones?
    • When was Biohaven Ltd.'s last earnings report?
    • When does Biohaven Ltd. report earnings?

    What is the ticker symbol for Biohaven Ltd.?

    The ticker symbol for Biohaven Ltd. is NYSE:BHVN

    Does Biohaven Ltd. pay dividends?

    No, Biohaven Ltd. does not pay dividends

    What sector is Biohaven Ltd. in?

    Biohaven Ltd. is in the Healthcare sector

    What industry is Biohaven Ltd. in?

    Biohaven Ltd. is in the Biotechnology industry

    What country is Biohaven Ltd. based in?

    Biohaven Ltd. is headquartered in United States

    When did Biohaven Ltd. go public?

    Biohaven Ltd.'s initial public offering (IPO) was on September 23, 2022

    Is Biohaven Ltd. in the S&P 500?

    No, Biohaven Ltd. is not included in the S&P 500 index

    Is Biohaven Ltd. in the NASDAQ 100?

    No, Biohaven Ltd. is not included in the NASDAQ 100 index

    Is Biohaven Ltd. in the Dow Jones?

    No, Biohaven Ltd. is not included in the Dow Jones index

    When was Biohaven Ltd.'s last earnings report?

    Biohaven Ltd.'s most recent earnings report was on August 11, 2025

    When does Biohaven Ltd. report earnings?

    The next expected earnings date for Biohaven Ltd. is November 10, 2025
    On this page